×
| Stock | Total Income | Net Profit | Net Sales | EPS | Market Cap (in Cr) | P/E |
|---|---|---|---|---|---|---|
| Shyama Computronics and Servic | 0.70 | 0.19 | 0.61 | NA | 4.02 | 30.9 |
| Triochem Products Ltd., | 4.59 | 0.88 | NA | 3.60 | 0 | |
| TORRENT PHARMACEUTICALS LTD. | 28420 | 5030 | 28090 | 14.88 | 1,02,861 | 55.2 |
| Max Healthcare Institute Limit | 19016.1 | 2388 | 18683.1 | 2.44 | 98211 | 92.6 |
| DR.REDDYS LABORATORIES LTD. | 85,314.00 | 14,042.00 | 83,812.00 | 16.94 | 96111 | 17.9 |
Torrent Pharmaceuticals Ltd., with Security Code 500420, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.
| Metrics | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,933.0 | 1,928.0 | 1,857.0 | 1,920.0 | 2,121.0 | 2,146.0 | 2,123.0 | 2,143.0 | 2,438.0 | 2,434.0 |
| Expenses | 1,268.0 | 1,308.0 | 1,272.0 | 1,342.0 | 1,384.0 | 1,410.0 | 1,422.0 | 1,427.0 | 1,539.0 | 1,513.0 |
| Operating Profit | 665.0 | 620.0 | 585.0 | 578.0 | 737.0 | 736.0 | 701.0 | 716.0 | 899.0 | 921.0 |
| OPM % | 34.4% | 32.16% | 31.5% | 30.1% | 34.75% | 34.3% | 33.02% | 33.41% | 36.87% | 37.84% |
| Other Income | 29.0 | 11.0 | 15.0 | 26.0 | 11.0 | 15.0 | -11.0 | 76.0 | 21.0 | -7.0 |
| Interest | 51.0 | 62.0 | 91.0 | 94.0 | 90.0 | 77.0 | 69.0 | 67.0 | 64.0 | 54.0 |
| Depreciation | 149.0 | 156.0 | 156.0 | 182.0 | 183.0 | 192.0 | 191.0 | 195.0 | 189.0 | 190.0 |
| Profit before tax | 494.0 | 413.0 | 353.0 | 328.0 | 475.0 | 482.0 | 430.0 | 530.0 | 667.0 | 670.0 |
| Tax % | 33.8% | 34.1% | 35.1% | 33.2% | 32% | 32.2% | 30.9% | 22.6% | 29.7% | 31.3% |
| Net Profit | 327.0 | 272.0 | 229.0 | 219.0 | 323.0 | 327.0 | 297.0 | 410.0 | 469.0 | 460.0 |
| EPS in Rs | 19.35 | 8.02 | 6.78 | 6.46 | 9.55 | 9.65 | 8.78 | 12.12 | 13.86 | 13.6 |
| Metrics | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 2,291.0 | 2,491.0 | 2,491.0 | 2,591.0 | 2,660.0 | 2,732.0 | 2,745.0 | 2,859.0 | 2,889.0 | 2,809.0 |
| Expenses | 1,612.0 | 1,767.0 | 1,764.0 | 1,800.0 | 1,835.0 | 1,863.0 | 1,862.0 | 1,955.0 | 1,950.0 | 1,895.0 |
| Operating Profit | 679.0 | 724.0 | 727.0 | 791.0 | 825.0 | 869.0 | 883.0 | 904.0 | 939.0 | 914.0 |
| OPM % | 29.6% | 29.1% | 29.2% | 30.5% | 31% | 31.8% | 32.2% | 31.6% | 32.5% | 32.5% |
| Other Income | 16.0 | -10.0 | 9.0 | 34.0 | 26.0 | 55.0 | 31.0 | 24.0 | -16.0 | 33.0 |
| Interest | 69.0 | 102.0 | 107.0 | 103.0 | 91.0 | 80.0 | 80.0 | 75.0 | 64.0 | 57.0 |
| Depreciation | 163.0 | 193.0 | 196.0 | 191.0 | 201.0 | 213.0 | 203.0 | 197.0 | 198.0 | 199.0 |
| Profit before tax | 463.0 | 419.0 | 433.0 | 531.0 | 559.0 | 543.0 | 631.0 | 656.0 | 661.0 | 691.0 |
| Tax % | 32.6% | 32.5% | 33.7% | 28.8% | 30.9% | 29.8% | 28.8% | 30.3% | 31.5% | 27.2% |
| Net Profit | 312.0 | 283.0 | 287.0 | 378.0 | 386.0 | 443.0 | 449.0 | 457.0 | 453.0 | 503.0 |
| EPS in Rs | 9 | 8 | 8 | 11 | 11 | 13 | 13 | 13 | 13 | 14 |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 10% |
| 5 Years: | 8% |
| 3 Years: | 10% |
| TTM: | 13% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 6% |
| 5 Years: | 13% |
| 3 Years: | 6% |
| TTM: | 56% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 19% |
| 5 Years: | 23% |
| 3 Years: | 30% |
| 1 Year: | 16% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 10% |
| 5 Years: | 7% |
| 3 Years: | 10% |
| TTM: | 8% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 9% |
| 5 Years: | 22% |
| 3 Years: | 8% |
| TTM: | 30% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 19% |
| 5 Years: | 23% |
| 3 Years: | 30% |
| 1 Year: | 16% |
Recent Bets
|
Date
|
Stock
|
Party
|
Deal
|
Trans.
|
Quan.
|
Price
|
Value
|
|---|